HB 2565

  • Washington House Bill
  • 2017-2018 Regular Session
  • Introduced in House
  • Passed House Feb 02, 2018
  • Passed Senate Feb 02, 2018
  • Governor

Concerning drug and gene therapy payment for medicaid managed care organizations.

Votes


Actions


Mar 08, 2018

Senate

By resolution, returned to House Rules Committee for third reading.

Feb 13, 2018

Senate

First reading, referred to Health & Long Term Care.

Feb 09, 2018

Senate

1st substitute bill substituted.

Senate

Floor amendment(s) adopted.

House

1st substitute bill substituted.

Senate

Third reading, passed; yeas, 98; nays, 0; absent, 0; excused, 0.

Senate

Rules suspended. Placed on Third Reading.

Feb 06, 2018

Senate

Placed on second reading by Rules Committee.

House

Placed on second reading by Rules Committee.

Feb 02, 2018

Senate

Referred to Rules 2 Review.

Senate

HCW - Majority; 1st substitute bill be substituted, do pass.

House

Referred to Rules 2 Review.

House

HCW - Majority; 1st substitute bill be substituted, do pass.

Jan 10, 2018

House

First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).

Bill Text

Bill Text Versions Format
Bill HTML
Substitute Bill HTML
Engrossed Substitute Bill HTML

Related Documents

Document Format
Digest HTML
Digest for Substitute HTML
Report for Engrossed Substitute HTML
Report HTML HTML
Amendment SLAT BLAC 091 HTML
Amendment SHMK BLAC 087 HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Washington State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.